CureVac N.V. (CVAC) Shareholder/Analyst Call Prepared Remarks Transcript

Group 1 - The Extraordinary General Meeting of Shareholders of CureVac N.V. was convened in connection with BioNTech's public exchange offer for all outstanding shares of CureVac N.V. [2] - Shareholders will vote on resolutions related to the proposed transaction with BioNTech, including corporate reorganization and the appointment of new members to CureVac's Management and Supervisory Board [2] - Key attendees at the meeting include CureVac's CEO, CBO, General Counsel, and representatives from Dutch Legal Counsel [3]